comparemela.com
  1. Home
  2. Live Updates
  3. Resistant Tumors - Breaking News

Resistant Tumors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genprex Collaborators Report Positive Preclinical Data With NPRL2 Gene Therapy Utilizing Non-Viral ONCOPREX® Nanoparticle Delivery System in Non-Small Cell Lung Cancer at the 2023 AACR Annual Meeting

/PRNewswire/ Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies.

United statesMark bergerJacka rothRodney varnerUniversity of texas md anderson cancer centerExchange commissionGenprex incAmerical association of cancer researchDrug administrationAmerican association of cancer researchTherapy induces effective anti tumor activityNon small cell lung cancerResistant tumorsHumanized mousePreclinical validationNanoparticle delivery system

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.